Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adma Biologics, Inc. (ADMA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adma Biologics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1368514.
Total stock buying since 2015: $51,646,538.
Total stock sales since 2015: $76,108,511.
Total stock option exercises since 2015: $14,952,193.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 632,621 | $12,867,767 | 479,180 | $2,129,200 |
| 2024 | 0 | $0 | 2,520,223 | $26,523,240 | 805,256 | $4,073,635 |
| 2023 | 155,000 | $579,670 | 2,583,538 | $10,669,063 | 2,909,721 | $8,500,103 |
| 2021 | 580,000 | $580,000 | 3,322,427 | $4,246,114 | 0 | $0 |
| 2020 | 5,276,255 | $17,726,014 | 0 | $0 | 0 | $0 |
| 2019 | 4,076,500 | $16,306,000 | 5,813,954 | $21,802,327 | 0 | $0 |
| 2018 | 155,754 | $744,503 | 17,182,320 | $0 | 0 | $0 |
| 2017 | 6,340,454 | $13,631,976 | 0 | $0 | 93,006 | $249,255 |
| 2016 | 249,039 | $1,618,753 | 0 | $0 | 0 | $0 |
| 2015 | 54,161 | $459,622 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 21,000 | $354,480 | 15,000 | $81,000 |
| 2025-07 | 0 | $0 | 63,000 | $1,175,580 | 47,500 | $265,450 |
| 2025-06 | 0 | $0 | 476,621 | $9,898,642 | 357,680 | $1,432,111 |
| 2025-05 | 0 | $0 | 30,000 | $591,085 | 24,000 | $134,639 |
| 2025-04 | 0 | $0 | 21,000 | $450,660 | 15,000 | $81,000 |
| 2025-03 | 0 | $0 | 21,000 | $397,320 | 15,000 | $81,000 |
| 2025-01 | 0 | $0 | 0 | $0 | 5,000 | $54,000 |
| 2024-11 | 0 | $0 | 63,967 | $1,350,453 | 9,000 | $97,200 |
| 2024-09 | 0 | $0 | 9,000 | $166,185 | 9,000 | $97,200 |
| 2024-08 | 0 | $0 | 847,256 | $14,791,445 | 787,256 | $3,879,235 |
| 2024-06 | 0 | $0 | 100,000 | $1,072,000 | 0 | $0 |
| 2024-03 | 0 | $0 | 1,500,000 | $9,143,157 | 0 | $0 |
| 2023-08 | 155,000 | $579,670 | 2,583,538 | $10,669,063 | 2,909,721 | $8,500,103 |
| 2021-10 | 580,000 | $580,000 | 0 | $0 | 0 | $0 |
| 2021-09 | 0 | $0 | 1,540,603 | $1,912,334 | 0 | $0 |
| 2021-08 | 0 | $0 | 1,781,824 | $2,333,780 | 0 | $0 |
| 2020-09 | 15,200 | $33,898 | 0 | $0 | 0 | $0 |
| 2020-08 | 34,500 | $99,174 | 0 | $0 | 0 | $0 |
| 2020-03 | 500,000 | $1,050,000 | 0 | $0 | 0 | $0 |
| 2020-02 | 4,726,555 | $16,542,942 | 0 | $0 | 0 | $0 |
| 2019-06 | 0 | $0 | 5,813,954 | $21,802,327 | 0 | $0 |
| 2019-05 | 4,076,500 | $16,306,000 | 0 | $0 | 0 | $0 |
| 2018-06 | 155,754 | $744,503 | 0 | $0 | 0 | $0 |
| 2018-05 | 0 | $0 | 17,182,320 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | Grossman Adam S (President and CEO) | Sale | 21,000 | 16.88 | 354,480 |
| 2025-08-15 | Grossman Adam S (President and CEO) | Option Ex | 15,000 | 5.40 | 81,000 |
| 2025-07-30 | Kestenberg-messina Kaitlin M. (COO and SVP, Compliance) | Option Ex | 2,500 | 8.98 | 22,450 |
| 2025-07-15 | Grossman Adam S (President and CEO) | Sale | 42,000 | 18.66 | 783,720 |
| 2025-07-15 | Grossman Adam S (President and CEO) | Option Ex | 30,000 | 5.40 | 162,000 |
| 2025-06-16 | Grossman Adam S (President and CEO) | Sale | 21,000 | 20.81 | 437,010 |
| 2025-06-16 | Grossman Adam S (President and CEO) | Option Ex | 15,000 | 5.40 | 81,000 |
| 2025-06-16 | Elms Steve | Sale | 194,749 | 20.24 | 3,941,719 |
| 2025-06-13 | Elms Steve | Sale | 137,931 | 20.82 | 2,871,723 |
| 2025-06-13 | Elms Steve | Option Ex | 332,680 | 3.91 | 1,301,111 |
| 2025-06-12 | Elms Steve | Sale | 92,941 | 21.69 | 2,015,890 |
| 2025-06-09 | Guiheen Lawrence P. | Sale | 20,000 | 20.96 | 419,200 |
| 2025-06-09 | Grossman Jerrold B | Sale | 10,000 | 21.31 | 213,100 |
| 2025-06-09 | Grossman Jerrold B | Option Ex | 10,000 | 5.00 | 50,000 |
| 2025-05-22 | Guiheen Lawrence P. | Sale | 1,221 | 20.12 | 24,566 |
| 2025-05-22 | Guiheen Lawrence P. | Option Ex | 1,221 | 5.96 | 7,277 |
| 2025-05-21 | Guiheen Lawrence P. | Sale | 7,779 | 20.32 | 158,069 |
| 2025-05-21 | Guiheen Lawrence P. | Option Ex | 7,779 | 5.96 | 46,362 |
| 2025-05-15 | Grossman Adam S (President and CEO) | Sale | 21,000 | 19.45 | 408,450 |
| 2025-05-15 | Grossman Adam S (President and CEO) | Option Ex | 15,000 | 5.40 | 81,000 |
| 2025-04-15 | Grossman Adam S (President and CEO) | Sale | 21,000 | 21.46 | 450,660 |
| 2025-04-15 | Grossman Adam S (President and CEO) | Option Ex | 15,000 | 5.40 | 81,000 |
| 2025-03-19 | Grossman Adam S (President and CEO) | Sale | 21,000 | 18.92 | 397,320 |
| 2025-03-19 | Grossman Adam S (President and CEO) | Option Ex | 15,000 | 5.40 | 81,000 |
| 2025-01-30 | Kestenberg-messina Kaitlin M. (COO and SVP, Compliance) | Option Ex | 5,000 | 10.80 | 54,000 |
| 2024-11-27 | Elms Steve | Option Ex | 9,000 | 10.80 | 97,200 |
| 2024-11-22 | Tade Brad L. (CFO and Treasurer) | Sale | 15,000 | 21.15 | 317,250 |
| 2024-11-22 | Grossman Adam S (President and CEO) | Sale | 48,967 | 21.10 | 1,033,203 |
| 2024-09-09 | Guiheen Lawrence P. | Sale | 9,000 | 18.46 | 166,185 |
| 2024-09-09 | Guiheen Lawrence P. | Option Ex | 9,000 | 10.80 | 97,200 |
| 2024-08-30 | Kestenberg-messina Kaitlin M. (COO and SVP, Compliance) | Sale | 24,150 | 16.90 | 408,062 |
| 2024-08-30 | Kestenberg-messina Kaitlin M. (COO and SVP, Compliance) | Option Ex | 24,150 | 3.90 | 94,185 |
| 2024-08-29 | Grossman Jerrold B | Sale | 136,861 | 17.27 | 2,364,000 |
| 2024-08-29 | Grossman Jerrold B | Option Ex | 136,861 | 6.81 | 931,612 |
| 2024-08-27 | Grossman Adam S (President and CEO) | Sale | 389,356 | 17.29 | 6,732,743 |
| 2024-08-27 | Grossman Adam S (President and CEO) | Option Ex | 389,356 | 3.13 | 1,219,852 |
| 2024-08-26 | Grossman Adam S (President and CEO) | Sale | 236,889 | 17.69 | 4,191,040 |
| 2024-08-26 | Grossman Adam S (President and CEO) | Option Ex | 236,889 | 6.90 | 1,633,586 |
| 2024-08-23 | Kwon Young | Sale | 60,000 | 18.26 | 1,095,600 |
| 2024-06-14 | Grossman Adam S (President,CEO, and Interim CFO) | Sale | 100,000 | 10.72 | 1,072,000 |
| 2024-03-19 | Elms Steve | Sale | 411,829 | 6.08 | 2,503,920 |
| 2024-03-18 | Elms Steve | Sale | 49,887 | 6.01 | 299,820 |
| 2024-03-15 | Elms Steve | Sale | 183,008 | 6.01 | 1,099,878 |
| 2024-03-14 | Elms Steve | Sale | 448,276 | 6.05 | 2,712,069 |
| 2024-03-13 | Elms Steve | Sale | 407,000 | 6.21 | 2,527,470 |
| 2023-08-30 | Grossman Jerrold B | Buy | 130,000 | 3.71 | 482,170 |
| 2023-08-24 | Kwon Young | Buy | 25,000 | 3.90 | 97,500 |
| 2023-08-22 | Fong Bryant | Sale | 1,433,304 | 3.87 | 5,545,453 |
| 2023-08-18 | Grossman Adam S (President and CEO) | Sale | 250,000 | 4.15 | 1,038,249 |
| 2023-08-16 | Grossman Adam S (President and CEO) | Sale | 3 | 4.38 | 13 |
| 2023-08-16 | Lenz Brian (EVP, CFO) | Sale | 178,184 | 4.45 | 793,453 |
| 2023-08-15 | Grossman Adam S (President and CEO) | Sale | 510,469 | 4.54 | 2,319,060 |
| 2023-08-15 | Grossman Adam S (President and CEO) | Option Ex | 2,100,459 | 2.92 | 6,135,440 |
| 2023-08-15 | Lenz Brian (EVP, CFO) | Sale | 211,578 | 4.60 | 972,835 |
| 2023-08-15 | Lenz Brian (EVP, CFO) | Option Ex | 809,262 | 2.92 | 2,364,663 |
| 2021-10-25 | Kwon Young | Buy | 100,000 | 1.00 | 100,000 |
| 2021-10-25 | Grossman Jerrold B | Buy | 100,000 | 1.00 | 100,000 |
| 2021-10-25 | Grossman Adam S (President and CEO) | Buy | 350,000 | 1.00 | 350,000 |
| 2021-10-25 | Lenz Brian (EVP, CFO) | Buy | 30,000 | 1.00 | 30,000 |
| 2021-09-30 | Edelman Joseph (10% Owner) | Sale | 137,495 | 1.12 | 153,994 |
| 2021-09-29 | Edelman Joseph (10% Owner) | Sale | 82,505 | 1.16 | 95,705 |
| 2021-09-28 | Edelman Joseph (10% Owner) | Sale | 40,603 | 1.22 | 49,535 |
| 2021-09-27 | Edelman Joseph (10% Owner) | Sale | 250,000 | 1.23 | 307,500 |
| 2021-09-24 | Edelman Joseph (10% Owner) | Sale | 250,000 | 1.26 | 315,000 |
| 2021-09-23 | Edelman Joseph (10% Owner) | Sale | 780,000 | 1.27 | 990,600 |
| 2021-08-19 | Edelman Joseph (10% Owner) | Sale | 350,352 | 1.24 | 434,436 |
| 2021-08-18 | Edelman Joseph (10% Owner) | Sale | 552,380 | 1.29 | 712,570 |
| 2021-08-17 | Edelman Joseph (10% Owner) | Sale | 879,092 | 1.35 | 1,186,774 |
| 2020-09-11 | Demski Martha J | Buy | 2,200 | 2.29 | 5,038 |
| 2020-09-10 | Grossman Jerrold B | Buy | 5,000 | 2.22 | 11,100 |
| 2020-09-08 | Mond James (EVP, CSO and CMO) | Buy | 4,000 | 2.20 | 8,800 |
| 2020-09-08 | Grossman Adam S (President and CEO) | Buy | 4,000 | 2.24 | 8,960 |
| 2020-08-21 | Grossman Jerrold B | Buy | 5,300 | 2.59 | 13,727 |
| 2020-08-13 | Demski Martha J | Buy | 2,000 | 2.88 | 5,760 |
| 2020-08-12 | Grossman Jerrold B | Buy | 10,200 | 2.88 | 29,426 |
| 2020-08-11 | Grossman Adam S (President and CEO) | Buy | 1,000 | 2.97 | 2,970 |
| 2020-08-11 | Lenz Brian (EVP, CFO) | Buy | 4,000 | 2.96 | 11,860 |
| 2020-08-10 | Mond James (EVP, CSO and CMO) | Buy | 7,000 | 2.88 | 20,146 |
| 2020-08-10 | Grossman Adam S (President and CEO) | Buy | 5,000 | 3.06 | 15,285 |
| 2020-03-19 | Edelman Joseph (10% Owner) | Buy | 500,000 | 2.10 | 1,050,000 |
| 2020-02-11 | Mond James (CSO and CMO) | Buy | 4,285 | 3.50 | 14,997 |
| 2020-02-11 | Guiheen Lawrence P. | Buy | 20,000 | 3.50 | 70,000 |
| 2020-02-11 | Grossman Jerrold B | Buy | 45,714 | 3.50 | 159,999 |
| 2020-02-11 | Grossman Adam S (President and CEO) | Buy | 85,714 | 3.50 | 299,999 |
| 2020-02-11 | Lenz Brian (EVP, CFO) | Buy | 7,142 | 3.50 | 24,997 |
| 2020-02-11 | Edelman Joseph (10% Owner) | Buy | 4,563,700 | 3.50 | 15,972,950 |
| 2019-06-06 | Biotest Divestiture Trust (10% Owner) | Sale | 5,813,954 | 3.75 | 21,802,327 |
| 2019-05-21 | Edelman Joseph (10% Owner) | Buy | 4,000,000 | 4.00 | 16,000,000 |
| 2019-05-17 | Mond James (EVP, CSO and CMO) | Buy | 4,500 | 4.00 | 18,000 |
| 2019-05-17 | Guiheen Lawrence P. | Buy | 25,000 | 4.00 | 100,000 |
| 2019-05-17 | Grossman Jerrold B | Buy | 12,000 | 4.00 | 48,000 |
| 2019-05-17 | Grossman Adam S (President and CEO) | Buy | 30,000 | 4.00 | 120,000 |
| 2019-05-17 | Lenz Brian (EVP, CFO) | Buy | 5,000 | 4.00 | 20,000 |
| 2018-06-08 | Guiheen Lawrence P. | Buy | 20,000 | 4.78 | 95,600 |
| 2018-06-08 | Grossman Jerrold B | Buy | 52,302 | 4.78 | 250,003 |
| 2018-06-08 | Grossman Adam S (President and CEO) | Buy | 73,222 | 4.78 | 350,001 |
| 2018-06-08 | Richman Eric I | Buy | 5,230 | 4.78 | 24,999 |
| 2018-06-08 | Lenz Brian (VP, CFO) | Buy | 5,000 | 4.78 | 23,900 |
| 2018-05-14 | Biotest Divestiture Trust (10% Owner) | Sale | 8,591,160 | .00 | 0 |
| 2018-05-14 | Biotest Pharmaceuticals Corp | Sale | 8,591,160 | .00 | 0 |
| 2017-11-09 | Biotest Pharmaceuticals Corp | Buy | 5,813,954 | 2.15 | 12,500,001 |
| 2017-11-09 | Mond James (EVP, CSO and CMO) | Buy | 10,000 | 2.15 | 21,500 |
| 2017-11-09 | Grossman Adam S (President and CEO) | Buy | 485,000 | 2.15 | 1,042,750 |
| 2017-11-09 | Richman Eric I | Buy | 25,000 | 2.15 | 53,750 |
| 2017-11-09 | Lenz Brian (VP, CFO) | Buy | 6,500 | 2.15 | 13,975 |
| 2017-07-13 | Grossman Jerrold B | Option Ex | 48,185 | 2.68 | 129,135 |
| 2017-07-13 | Grossman Adam S (President and CEO) | Option Ex | 42,021 | 2.68 | 112,616 |
| 2017-07-13 | Richman Eric I | Option Ex | 2,800 | 2.68 | 7,504 |
| 2016-05-03 | Mond James (CSO/CMO) | Buy | 770 | 6.50 | 5,005 |
| 2016-05-03 | Grossman Jerrold B | Buy | 45,769 | 6.50 | 297,498 |
| 2016-05-03 | Grossman Adam S (President & CEO) | Buy | 200,000 | 6.50 | 1,300,000 |
| 2016-05-03 | Lenz Brian (Chief Financial Officer) | Buy | 2,500 | 6.50 | 16,250 |
| 2015-12-18 | Grossman Jerrold B | Buy | 4,000 | 8.48 | 33,920 |
| 2015-12-18 | Grossman Adam S (President & CEO) | Buy | 6,400 | 8.47 | 54,227 |
| 2015-12-08 | Grossman Adam S (President & CEO) | Buy | 300 | 8.99 | 2,697 |
| 2015-12-07 | Grossman Jerrold B | Buy | 500 | 9.01 | 4,502 |
| 2015-12-07 | Grossman Adam S (President & CEO) | Buy | 200 | 9.02 | 1,803 |
| 2015-12-02 | Grossman Jerrold B | Buy | 6,000 | 9.16 | 54,960 |
| 2015-12-02 | Grossman Adam S (President & CEO) | Buy | 2,250 | 9.15 | 20,589 |
| 2015-12-02 | Lenz Brian (Chief Financial Officer) | Buy | 1,000 | 9.16 | 9,156 |
| 2015-12-01 | Grossman Adam S (President & CEO) | Buy | 1,800 | 9.17 | 16,513 |
| 2015-11-25 | Grossman Adam S (President & CEO) | Buy | 1,800 | 9.18 | 16,529 |
| 2015-11-20 | Grossman Adam S (President & CEO) | Buy | 2,861 | 9.19 | 26,289 |
| 2015-11-19 | Grossman Adam S (President & CEO) | Buy | 1,000 | 9.13 | 9,134 |
| 2015-03-19 | Grossman Adam S (President & CEO) | Buy | 2,000 | 8.50 | 16,996 |
| 2015-03-19 | Lenz Brian (Chief Financial Officer) | Buy | 750 | 8.91 | 6,682 |
| 2015-03-17 | Grossman Jerrold B | Buy | 500 | 8.01 | 4,004 |
| 2015-03-17 | Grossman Adam S (President & CEO) | Buy | 5,500 | 7.98 | 43,879 |
| 2015-03-16 | Mond James (CSO/CMO) | Buy | 1,250 | 8.02 | 10,025 |
| 2015-03-16 | Guiheen Lawrence P. | Buy | 1,000 | 7.96 | 7,959 |
| 2015-03-16 | Grossman Jerrold B | Buy | 1,200 | 8.00 | 9,597 |
| 2015-03-16 | Grossman Adam S (President & CEO) | Buy | 9,100 | 7.99 | 72,690 |
| 2015-03-16 | Lenz Brian (Chief Financial Officer) | Buy | 1,250 | 7.97 | 9,961 |
| 2015-03-13 | Richman Eric I | Buy | 3,500 | 7.86 | 27,510 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADMA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adma Biologics, Inc. (symbol ADMA, CIK number 1368514) see the Securities and Exchange Commission (SEC) website.